相关实验视频
Updated: Sep 12, 2025

05:52
Prehospital Thrombolysis: A Manual from Berlin
Published on: November 26, 2013
22.0K
在急性缺血性中风患者中,特内克与阿尔特相比:更新的系统性审查和元分析
Abdelmonam M Hagag1, Muhammed E Kormod2, Mahmoud Elmwafy Ads3
1Faculty of Medicine, Zagazig University, As Sanafin Al Qibliyyah, Minya Al Qamh, Zagazig, Sharqia, Egypt. abdelmonamhagag@gmail.com.
European journal of medical research
|August 8, 2025
概括
与阿尔特相比,0.25 mg/kg的特内克显著改善了急性缺血性中风患者的功能结果. 这一剂量是一种安全有效的替代品,没有增加死亡率.
科学领域:
- 神经学 神经学
- 药理学 药理学是指药理学的学科.
- 临床试验 临床试验
背景情况:
- 卒中仍然是全球死亡和残疾的主要原因之一.
- 阿尔特普拉斯被FDA批准用于在4.5小时内治疗急性缺血性中风.
- 丁氏甲呈现出一种潜在的替代治疗方法.
研究的目的:
- 为了比较tenecteplase与alteplase的安全性和疗效.
- 为了确定用于急性缺血性中风治疗的基的最佳剂量.
主要方法:
- 按照PRISMA 2020指南进行随机对照试验 (RCT) 的系统审查和元分析.
- 在主要数据库 (PubMed,Scopus,Web of Science,Cochrane Library) 进行了搜索,直到2024年11月.
- 使用偏差风险2工具评估功能结果 (90天的mRS 0-1) 和死亡率.
主要成果:
- 包括13个涉及9053名患者的RCT.
- 乙烯基0.25 mg/kg显示出优异的功能结果 (p=0.008) 没有增加死亡率 (p=0.37).
- 其他甲剂量 (0.1,0.4 mg/kg) 与阿尔特相比没有显著差异.
结论:
- 0.25毫克/千克的丁氏甲在急性缺血性中风中优异的功能性结果方面优于阿尔特氏甲.
- 这一剂量在重大神经改善或死亡率方面并不劣.
- 0.25毫克/公斤的丁氏甲是一种最佳和可取的替代品.
相关概念视频
Acute Coronary Syndrome I: Introduction
73
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
73
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
44
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
44
Acute Coronary Syndrome IV: Interprofessional Care
28
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
28
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
645
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
645
Venous Thrombosis III: Interprofessional Care
22
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
22
Cardiopulmonary Resuscitation IV: Pharmacological Management
77
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
77

